People · Operator
Named in public records as an officer, director or promoter · active 2024–2025 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Medsyn Biopharma LLC | — | Pharmaceuticals | Series A | $19.6M | $33.0M | 2024 |
| Esanik Therapeutics, Inc. | — | Pharmaceuticals | Seed | $3.3M | $13.1M | 2024 |
John Mel Sorensen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Mel Sorensen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gilbert S Omenn | 1 | 3 |
| Brian Mel Wood | 1 | 2 |
| Martin Mel Matthew | 1 | 1 |
| Shaomeng Mel Wang | 1 | 1 |
| Mel Sorensen John | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.